Abbot Targets Amneal In Latest Suit Over Generic Niaspan
Abbott Laboratories on Monday fired off the latest in a series of suits defending its cholesterol drug Niaspan in Delaware federal court, aiming to block Amneal Pharmaceuticals LLC from producing a...To view the full article, register now.
Already a subscriber? Click here to view full article